the present invention relates to methods of monitoring the mass is needed in this individual by determining the level of adequacy of renal functions indy \u0432\u0438\u0434\u0443\u0443\u043c\u0430 and destination or the introduction of individual \u0442\u0435\u0440\u0430\u043f\u0435\u0432\u0442\u0438\u0447\u0435\u0441\u043a\u0438 effective amount of (r) - 8 - chlorine - 1 - methyl - 2,3,4,5-tetrachlorophenol of 1h - 3 - \u0431\u0435\u043d\u0437\u0430\u0437\u0435\u043f\u0438\u043d\u0430 or \u0444\u0430\u0440\u043c\u0430\u0446\u0435\u0432\u0442\u0438\u0447\u0435\u0441\u043a\u0438 priya \u043c\u043b\u0435\u043c\u044b\u0445 salt, \u0441\u043e\u043b\u044c\u0432\u0430\u0442\u0430 or \u0433\u0438\u0434\u0440\u0430\u0442\u0430 providedthat the individual is the level of adequacy of renal functions, selected from the group consisting of lack of kidney deficiency, kidney not weak sufficiency and moderate renal failure.in addition, the invention relates to a method of screening an individual for the treatment of (r) - 8 - chlorine - 1 - methyl - 2,3,4,5-tetrachlorophenol of 1h - 3 - \u0431\u0435\u043d\u0437\u0430\u0437\u0435\u043f\u0438\u043d\u043e\u043c or \u0444\u0430\u0440\u043c\u0430\u0446\u0435\u0432\u0442\u0438\u0447\u0435\u0441\u043a\u0438 acceptable to liu, \u0441\u043e\u043b\u044c\u0432\u0430\u0442\u043e\u043c or \u0433\u0438\u0434\u0440\u0430\u0442\u043e\u043c of many individuals in need of the control of renal function by determining the level of the individual and the the selection of the individual for the treatment of (r) - 8 - chlorine - 1 - methyl - two, three, four,5 of 1h - 3 - \u0431\u0435\u043d\u0437\u0430\u0437\u0435\u043f\u0438\u043d\u043e\u043c or \u0444\u0430\u0440\u043c\u0430\u0446\u0435\u0432\u0442\u0438\u0447\u0435\u0441\u043a\u0438 acceptable salt, \u0441\u043e\u043b\u044c\u0432\u0430\u0442\u043e\u043c or \u0433\u0438\u0434\u0440\u0430\u0442\u043e\u043c, if the individual is the level of adequacy of renal s \u0443\u043d\u043a\u0446\u0438\u0438, sele
